medigraphic.com
ISSN 1405-8790 (Print)

2003, Number 2

<< Back Next >>

Rev Mex Med Fis Rehab 2003; 15 (2)

Amyotrophic lateral sclerosis. Monograph

González DN, Escobar BE, Escamilla CC

Language: Spanish
References: 29
Page: 44-54
PDF size: 90.76 Kb.


ABSTRACT

The amyotrophic lateral sclerosis, is historically an important illness inside the neurodegeneration diseases, by the different demonstrations that involve so much signs of lower and upper motor neuron. The present monograph intends to offer a view of the recent theories on its pathogenesis little understood; as well as the characteristic clinical picture and the present diagnostic criteria to arrive at its diagnose opportune, and the methods of laboratory-cabinet that can be of utility to confirm or to rule out the disease; at the same time to contribute a guideline for the medical management medico and rehabilitation, of is devastating illness.


REFERENCES

  1. Fustinioni JC, Pérgola F. Neurología en esquemas. Buenos Aires Argentina: Editorial Médica Panamericana, 1997: 117-123.

  2. Cotran RS, Kumar V, Collins T. Patología estructural y funcional de Robbins. Sexta Edición. Madrid España: McGraw-Hill, 2000: 1386-87.

  3. Braunwald E, Fauci AS, Kasper DL. Principios de medicina interna de Harrison. Quinceava edición. México D.F.: McGraw-Hill, 2001: Vol. II: 2821-2825.

  4. Pasantes H, Arias C, Massieu L, Zentella A, Tapia R. Enfermedades neurodegenerativas: Mecanismos celulares y moleculares. México. Fondo de Cultura Económica, 1999: 97-102.

  5. Lomen-Hoerth C, Anderson T, Miller B. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 2002; 59: 1077-79.

  6. Cluskey S, Ramsden DB. Mechanisms of neurodegeneration in amyotrophic lateral sclerosis. J Clin Pathol Mol Pathol 2001; 54: 386-92.

  7. Rowland LP, Shneider NA. Amyotrophic Lateral Sclerosis. N Engl J Med 2001; 344(22): 1688-1700.

  8. Lechtzin N, Wiener CM, Clawson L, Chaudhry V, Diette GB. Hospitalization in amyotrophic lateral sclerosis: Causes, cost and outcomes. Neurology 2001; 56: 753-57.

  9. Hardiman O. Symptomatic treatment of respiratory and nutritional failure in amyotrophic lateral sclerosis. J Neurol 2000; 247: 245-51.

  10. Roman GC. Neuroepidemiology of amyotrophic lateral sclerosis: clues to aetiology and pathogenesis. J Neurol Neurosurg Phychiatry 1996; 61(2): 131-37.

  11. Hand CK, Rouleau GA. Familial amyotrophic lateral sclerosis. Muscle Nerve 2002; 25: 135-159.

  12. Brown RH. Amyotrophic lateral sclerosis: insights from genetics. Arch Neurol 1997; 54(10): 1246-1250.

  13. El Escorial revisited. Revised criteria for the diagnosis of amyotrophic lateral sclerosis. World Federation of Neurology ALS Website. Disponible en http://www.wfnals.org/guidelines/1998elescorial/elescorial1998app3.htm Accesado el 28/06/2003.

  14. Hiroshi M. Diagnosis and progression of ALS. Neurology 1997; 48(S4): 2S-8S.

  15. The ALS CNTF Treatment Study (ACTS): The Amyotrophic Lateral Sclerosis Functional Rating Scale: Assessment of Activities of Daily Living in Patients With Amyotrophic Lateral Sclerosis. Arch Neurol 1996; 53(2): 141-47.

  16. de Belleroche J, Orrell R, King A. Familial amyotrophic lateral sclerosis/motor neurone disease (FALS): a review of current developments. J Med Genet 1995; 32(11): 841-47.

  17. Chió A. ISIS Survey: an international study on the diagnostic process and its implications in amyotrophic lateral sclerosis. J Neurol 1999; 246(S3): III/1-III/5.

  18. Cwik VA, Hanstock CC, Alen PS, Wayme MW. Estimation of brainstem neuronal loss in amyotrophic lateral sclerosis with in vivo proton magnetic resonance spectroscopy. Neurology 1998; 50(1): 72-77.

  19. Bryan WW, Reisch JS, McDonald G, Herbelin LL, Barohn RJ, Fleckenstein JL. Magnetic resonance imaging of muscle in amyotrophic lateral sclerosis. Neurology 1998; 51(1): 110-13.

  20. Ross MA, Miller RG, Berchert LR y col. Toward earlier diagnosis of amyotrophic lateral sclerosis: Revised Criteria. Neurology 1998; 50(3): 768-72.

  21. Borasio GD, Voltz R. Palliative care in amyotrophic lateral sclerosis. J Neurol 1997; 244(S4): S11-S17.

  22. Miller RF, Sufit R. New approaches to the treatment of ALS. Neurology 1997; 48(S4): 28S-32S.

  23. Hugon J. Amyotrophic Lateral Sclerosis Therapy: targets for the future. Neurology 1996; 47(S6): 251S-254S.

  24. Sufit R. Symptomatic treatment of ALS. Neurology 1997; 48(S4): 15S-22S.

  25. Farreras, Rozman. Medicina Interna. Catorceava edición. Madrid España: Ediciones Harcourt, 2000.

  26. Stokes M. Colección de Fisioterapia: Rehabilitación Neurológica. Primera edición. Madrid España: Ediciones Harcourt, 2000: 215-223.

  27. Dumitru D. Electrodiagnostic Medicine. Filadelfia, Estados Unidos: Hanley & Belfus. 1994: 405.

  28. Netter FH. Colección Netter de ilustraciones médicas. Tomo I Sistema Nervioso, Parte 2 Trastornos neurológicos y neuromusculares. Barcelona España: Masson, S.A., 1987: 208-210.

  29. Arrabal CMC, Fernández MF, Luque SA y col. Fisioterapia y esclerosis lateral amiotrófica. Fisioterapia 2000; 22(4): 199-205.




2020     |     www.medigraphic.com